Simbrinza Eye Drops 1%/0.2% – Brinzolamide & Brimonidine Eye Drops

Simbrinza Eye Drops 1%/0.2% is a prescription ophthalmic suspension used to reduce elevated pressure inside the eye. It contains two active ingredients: brinzolamide 1% and brimonidine tartrate 0.2%. These medicines work through different mechanisms to help lower intraocular pressure (IOP).

Simbrinza is primarily prescribed for adults with open-angle glaucoma or ocular hypertension, particularly when treatment with a single glaucoma medicine does not provide adequate control of eye pressure.

High pressure inside the eye can damage the optic nerve over time. Lowering IOP is an important part of glaucoma management and can help reduce the risk of progressive vision loss. Simbrinza should be used exactly as directed by an ophthalmologist or other qualified healthcare professional.

Active Ingredients

Each millilitre of Simbrinza ophthalmic suspension contains:

• Brinzolamide 1% (10 mg/mL)
• Brimonidine tartrate 0.2% (2 mg/mL)

Brinzolamide is a carbonic anhydrase inhibitor, while brimonidine is an alpha-2 adrenergic receptor agonist. Both help reduce the production of aqueous fluid in the eye, thereby lowering intraocular pressure.

What Is Simbrinza Used For?

Simbrinza is indicated for reducing elevated intraocular pressure in patients with:

• Open-angle glaucoma
• Ocular hypertension

It may be prescribed when one glaucoma medication alone does not reduce eye pressure sufficiently.

Glaucoma can progress without obvious symptoms in its early stages. Regular eye examinations and appropriate treatment are therefore important for people diagnosed with glaucoma or at increased risk of developing it.

How Does Simbrinza Work?

Simbrinza combines two medicines with complementary actions.

Brinzolamide inhibits carbonic anhydrase in the eye, reducing the formation of aqueous humor. Less fluid production can result in lower pressure within the eye.

Brimonidine stimulates alpha-2 adrenergic receptors and also decreases aqueous humor production. Together, the two active ingredients can provide greater IOP reduction than either component used alone in some patients.

How to Use Simbrinza Eye Drops

Shake the bottle well before each use because Simbrinza is an ophthalmic suspension. The U.S. prescribing information recommends one drop in the affected eye(s) three times daily. If another topical eye medicine is also being used, the products should generally be administered at least five minutes apart.

Always follow the dosage prescribed by your eye specialist. Do not increase the number of drops or frequency of application unless your healthcare professional specifically instructs you to do so.

General application technique

1. Wash and dry your hands.
2. Shake the Simbrinza bottle well.
3. Tilt your head back and gently pull down the lower eyelid.
4. Place one drop into the pocket created by the lower eyelid.
5. Avoid touching the dropper tip to your eye, eyelids, fingers or other surfaces.
6. Close your eye gently after applying the drop.
7. If instructed by your healthcare professional, gently close the eye and apply pressure near the inner corner to reduce drainage into the nose.
8. Replace the cap securely after use.

Simbrinza Eye Drops Benefits

When prescribed appropriately, Simbrinza may provide several treatment benefits:

• Helps lower elevated intraocular pressure
• Combines two IOP-lowering medicines in one formulation
• Used for open-angle glaucoma and ocular hypertension
• Can be useful when single-drug therapy does not provide sufficient pressure reduction
• Convenient topical ophthalmic administration

Treatment response varies between patients, so your ophthalmologist may monitor your eye pressure regularly and adjust treatment when necessary.

Possible Side Effects

Like other prescription medicines, Simbrinza can cause side effects.

Commonly reported reactions include:

• Blurred vision
• Eye irritation or discomfort
• Eye redness
• Eye pain
• Dry eye
• Allergic reactions affecting the eye
• Bad or unusual taste
• Dry mouth
• Drowsiness
• Dizziness

The official U.S. labeling reports blurred vision, eye irritation, altered taste, dry mouth and eye allergy among the more common adverse reactions.

Seek urgent medical attention if you develop signs of a serious allergic or hypersensitivity reaction, including severe rash, skin peeling, swelling, or breathing difficulties. Serious sulfonamide-related hypersensitivity reactions are an important warning because brinzolamide belongs to the sulfonamide class.

Important Precautions

Tell your doctor about all medicines and supplements you take before starting Simbrinza.

Your doctor should know if you have:

• Kidney problems
• Liver problems
• Corneal or eye-surface problems
• Cardiovascular disease
• Blood-pressure problems
• Circulation problems
• A history of serious sulfonamide allergy
• Narrow-angle or other types of glaucoma

Simbrinza may not be appropriate for people with severe kidney impairment, and it is contraindicated in patients with hypersensitivity to its components.

Simbrinza is also not intended for children under two years of age, and pediatric use should be determined by an appropriate specialist.

Contact Lenses

Remove soft contact lenses before applying Simbrinza. Certain formulations contain preservatives that may be absorbed by contact lenses. Follow your doctor's or pharmacist's instructions regarding when contact lenses can be replaced after using the drops.

Pregnancy and Breastfeeding

If you are pregnant, planning to become pregnant, or breastfeeding, discuss Simbrinza with your doctor before using it. Your healthcare professional can evaluate the potential benefits and risks and determine whether an alternative treatment is more appropriate.

Storage

Store Simbrinza according to the instructions on the product packaging and pharmacy label. Current Australian consumer information advises storage below 25°C and not freezing the medicine.

Keep the bottle away from children and do not use the product beyond the recommended period after opening.

Frequently Asked Questions

1. What is Simbrinza Eye Drops used for?

Simbrinza is used to reduce elevated pressure inside the eye in adults with open-angle glaucoma or ocular hypertension when a single medicine may not provide sufficient pressure control.

2. What are the ingredients in Simbrinza?

Simbrinza contains brinzolamide 1% and brimonidine tartrate 0.2% as its active ingredients.

3. How often should Simbrinza be used?

The U.S. prescribing information recommends one drop in the affected eye(s) three times daily. Follow the specific instructions provided by your doctor.

4. Should Simbrinza be shaken before use?

Yes. Simbrinza is an ophthalmic suspension and should be shaken well before each use.

5. Can Simbrinza be used with other eye drops?

It may be prescribed alongside other topical glaucoma medicines. When using multiple eye drops, the U.S. labeling recommends administering them at least five minutes apart.

6. Can Simbrinza cause blurred vision?

Yes. Blurred vision is one of the commonly reported adverse reactions. If your vision remains significantly blurred or worsens, contact your eye-care professional.

7. Can I wear contact lenses while using Simbrinza?

Soft contact lenses should generally be removed before applying the drops. Follow the instructions provided with your specific product and by your healthcare professional.

8. What happens if I miss a dose?

Use the next dose according to your normal schedule. Do not double the dose to compensate for a missed application. If you frequently forget doses, speak with your pharmacist or doctor.

9. Can I stop Simbrinza when my eyes feel better?

Do not stop glaucoma treatment without speaking with your doctor. Glaucoma can progress without noticeable symptoms, and maintaining appropriate eye pressure is an important part of treatment.

10. Is Simbrinza available without a prescription?

Simbrinza is a prescription medicine. It should be used under the supervision of an appropriate healthcare professional.

Final Summary

Simbrinza Eye Drops 1%/0.2% combines brinzolamide and brimonidine in a single ophthalmic suspension to help reduce elevated intraocular pressure. It is prescribed for conditions including open-angle glaucoma and ocular hypertension, particularly when treatment with one medicine alone is not sufficient.

Because glaucoma treatment needs to be individualized, Simbrinza should be used only according to your healthcare professional's instructions. Regular eye-pressure monitoring and follow-up examinations are important to assess whether treatment is working effectively.